The expanding role of HMG-CoA reductase inhibitors (statins) in the prevention and treatment of ischemic heart disease

2001 ◽  
Vol 26 (12) ◽  
pp. 734-764 ◽  
Author(s):  
Robert Chilton ◽  
Robert A. O'Rourke
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Ischemic Heart ◽  
Hmg Coa Reductase ◽  
Reductase Inhibitors ◽  
Prevention And Treatment ◽  
Hmg Coa Reductase Inhibitors ◽  
Coa Reductase

scholarly journals Are all HMG-CoA reductase inhibitors protective against ischemic heart disease?

1999 ◽  
Vol 114 (supplement) ◽  
pp. 142-149 ◽  
Author(s):  
Kazuo Ichihara ◽  
Kumi Satoh ◽  
Atsuko Yamamoto ◽  
Katsuji Hoshi
Keyword(s):  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Ischemic Heart ◽  
Hmg Coa Reductase ◽  
Reductase Inhibitors ◽  
Hmg Coa Reductase Inhibitors ◽  
Coa Reductase

Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease

2002 ◽  
Vol 105 (4) ◽  
pp. 285-290 ◽  
Author(s):  
Ingebjørg Seljeflot ◽  
Serena Tonstad ◽  
Ingvar Hjermann ◽  
Harald Arnesen
Keyword(s):  
Coronary Heart Disease ◽  
Heart Disease ◽  
Hmg Coa Reductase ◽  
Reductase Inhibitors ◽  
Hmg Coa Reductase Inhibitors ◽  
Coa Reductase

Role of HMG-CoA Reductase Inhibitors in Neurological Disorders

Drugs ◽  
2007 ◽  
Vol 67 (15) ◽  
pp. 2111-2120 ◽  
Author(s):  
Allison B Reiss ◽  
Elzbieta Wirkowski
Keyword(s):  
Neurological Disorders ◽  
Hmg Coa Reductase ◽  
Reductase Inhibitors ◽  
Hmg Coa Reductase Inhibitors ◽  
Coa Reductase
Sign in / Sign up

Export Citation Format

Share Document